We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Tongue Analysis Model 98% Accurate in Detecting Diseases

By LabMedica International staff writers
Posted on 13 Aug 2024

Tongue color is a critical health indicator used to identify diseases and gauge their progression. More...

Various characteristics of the tongue, such as its color, shape, and coating, can signal different health conditions. For instance, a yellow tongue often indicates diabetes, while a purple tongue with a thick coating might suggest cancer. Patients with acute strokes typically have unusually shaped, red tongues. A white tongue could mean anemia; a deep red tongue is frequently seen in severe COVID-19 cases; and indigo or violet tongues may point to vascular, gastrointestinal issues, or asthma. Leveraging this concept, artificial intelligence (AI) is now modernizing a 2000-year-old practice from traditional Chinese medicine that involves diagnosing health conditions by examining the tongue.

Researchers from Middle Technical University (MTU, Baghdad, Iraq) and the University of South Australia (UniSA, Adelaide, Australia) conducted experiments utilizing AI to analyze tongue color for diagnosing diseases. They trained machine learning algorithms using 5260 images and collected 60 additional tongue images from patients with various health conditions at two teaching hospitals in the Middle East. Their imaging system proposed in a new paper published in Technologies analyzes tongue color to offer immediate diagnostic insights, demonstrating AI's potential to significantly advance medical practice.

In their study, cameras positioned 20 centimeters from subjects captured images of their tongues, and the AI system assessed the health conditions in real-time. The AI model successfully correlated tongue colors with specific diseases in nearly all cases, achieving a 98% accuracy rate in diagnosing a variety of conditions including diabetes, stroke, anemia, asthma, liver and gallbladder diseases, COVID-19, and various vascular and gastrointestinal issues by analyzing tongue color. The researchers anticipate that in the future, smartphones could be employed to perform similar diagnoses, enhancing accessibility and convenience in medical diagnostics.

“These results confirm that computerized tongue analysis is a secure, efficient, user-friendly and affordable method for disease screening that backs up modern methods with a centuries-old practice,” said co-author UniSA Professor Javaan Chahl.

Related Links:
MTU
UniSA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.